In cell models that mimicked liver cells of patients with the rare disease Friedreich's ataxia (FA), a widely used cholesterol-lowering drug was found to increase a precursor of HDL (high-density lipoprotein), the 'good cholesterol,' in preclinical studies.
from Medindia Health News https://ift.tt/2JWUV7S
No comments:
Post a Comment